At the third Helmholtz Munich Expert Hour at the German Bundestag on June 4, 2024, the cutting-edge research center provided information on the potential of artificial intelligence (AI) and new technologies to improve medicine in the areas of…
A new study found that hypertension patients who took their blood pressure medication at a time aligned with their body clock had a reduced risk of heart attack.
This year, the highest award of the German Diabetes Association (DDG) – the Paul Langerhans Medal – is awarded to Prof. Dr. med. Anette-Gabriele Ziegler. The Director of the Institute of Diabetes Research at Helmholtz Munich and scientist at the…
Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) collaborates within a European network to develop new…
Prof. Anette-Gabriele Ziegler about her contribution to novel therapies for type 1 diabetes.
Every year, the German Center for Diabetes Research (DZD) honors young researchers at the beginning of their careers with a DZD Award. This internal award recognizes outstanding scientific achievements in applied or clinical research presented at…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: